Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(33%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
3
33%
Ph phase_2
4
44%
Ph early_phase_1
1
11%
Ph not_applicable
1
11%

Phase Distribution

4

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting3
Not yet recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (11.1%)
Phase 13 (33.3%)
Phase 24 (44.4%)
N/A1 (11.1%)

Trials by Status

completed444%
recruiting333%
not_yet_recruiting111%
suspended111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9